Litcius/Paper detail

Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia

Huafeng Wang, Chang Yang, Ting Shi, Yi Zhang, Jiejing Qian, Yungui Wang, Yongxian Hu, Liping Mao, Xiujin Ye, Fang Liu, Zhenfang Xi, Lihong Shou, Caiyun Fu, Hua Naranmandura, Jie Jin, Hong‐Hu Zhu

2022Blood Cancer Journal28 citationsDOIOpen Access PDF

Topics & Concepts

PonatinibVenetoclaxLymphoblastic LeukemiaMedicineCancer researchLeukemiaInternal medicineOncologyMyeloid leukemiaDasatinibChronic lymphocytic leukemiaImatinibChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchAcute Lymphoblastic Leukemia research
Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia | Litcius